| cytokines |
drug |
7 |
4 |
systemic cytokine |
| cytosine |
drug |
4 |
1 |
|
| Czech Republic |
cohort |
3 |
— |
|
| DAGLA |
drug |
3 |
2 |
DAGLα, DAGL∝, diacylglycerol lipase alpha |
| daily smoking |
phenotype |
7 |
5 |
cigarette smoking, daily smokers, daily smoking, daily smoking rates, smoked cigarettes every day for ≥1 month, smoking, smoking on all of the past 30 days, tobacco smoking |
| D allele |
variant |
3 |
3 |
D, d |
| DALRD3 |
gene |
2 |
2 |
DALR Anticodon Binding Domain Containing 3, DALR anticodon binding domain containing 3 |
| damaging variants |
variant |
2 |
2 |
de novo damaging variants, deleterious variants |
| DAMGO |
drug |
5 |
5 |
D-Ala2-MePhe4-Gly-ol5-enkephalin, [3H]-D-Ala2, N-MePhe4, Gly-ol]-enkephalin, [D-Ala 2, N-MePhe4, Gly-ol]-enkephalin, [D-Ala2, N-MePhe4, Gly-ol]-enkephalin, [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin |
| DAMPs |
drug |
3 |
3 |
damage-associated molecular patterns |
| Danio rerio |
cohort |
5 |
2 |
DANRE, zebrafish |
| DAPI |
drug |
22 |
5 |
4', 6-diamidino-2-phenylindole, 4',6-diamidino-2-phenylindole, 4,6-diamidino-2-phenylindole, 4′,6-diamidino-2-phenylindole |
| DAPT |
drug |
2 |
1 |
N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester, Notch signaling inhibitor DAPT, γ secretase inhibitor, γ‑secretase inhibitor DAPT |
| DARPP-32 |
drug |
3 |
4 |
PPP1R1B, dopamine- and cyclic AMP-regulated phosphoprotein |
| DAT1 VNTR |
variant |
5 |
3 |
DAT1 variable number tandem repeat, VNTR, VNTR in DAT1 |
| datasets |
cohort |
5 |
2 |
243 datasets, datasets included in our study, two datasets |
| Daxx |
gene |
2 |
2 |
Daxx, death-associated protein 6 |
| DBA/2J |
cohort |
12 |
8 |
D2, DBA/2J, DBA/2J mice, DBA/2J mouse, DBA/2j mice, DBA2J, alcohol-avoiding DBA/2J |
| dbGaP |
cohort |
23 |
12 |
Database of Genotypes and Phenotypes, NCBI database of Genotypes and Phenotypes, database of Genotypes and Phenotypes, dbGaP repository, phs000417.v2.p1 |
| dbGAP samples |
cohort |
2 |
1 |
dbGAP |
